1 withdrawn. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Withdrawn 1 |
Follow Connect Biopharm LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis CBP-201, Placebo - Atopic Dermatitis | Phase 3 | Withdrawn | Connect Biopharm LLC | 2022-12-01 | 2023-03-21 |
Dermatitis, Atopic (1) · Eczema (1) · Hypersensitivity (1) · Pruritus (1)
Suzhou Connect (1)